Adma Biologics Inc
ADMA
Market Cap$4.92B
Close$
$7.07
65.7% downside
Current Fair Value
65.7% downsideOvervalued by 65.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.92 Billion |
|---|---|
| Enterprise Value | $4.95 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.85 |
| Beta | 0.47 |
| Outstanding Shares | 237,775,476 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 23.7 |
|---|---|
| PEG | 46.38 |
| Price to Sales | 20.61 |
| Price to Book Ratio | 20.61 |
| Enterprise Value to Revenue | 10.78 |
| Enterprise Value to EBIT | 32.72 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Insider Trades
ESG Score
No data